Javascript must be enabled to continue!
Study of digoxin use in a public health unit
View through CrossRef
Digoxin is used for heart failure associated to systolic dysfunction and high ventricular rate. It has a narrow therapeutic range and intoxication may occur due to drug interactions or comorbidities. The aim of this work was to study digoxin use in a public health unit delineating the profile of patients susceptible to digitalis intoxication. Medical records belonging to patients admitted to the cardiomyopathy ward of the health unit (2009-2010) and in use of digoxin were analyzed. Among 647 patients admitted, 185 individuals using digoxin and possessed records available. The registration of plasma digoxin concentration was found in 80 records and it was out of the therapeutic range in 42 patients (52.5%). This group of individuals was constituted mainly by males patients (79%), functional class III of heart failure (65%), exhibiting renal failure (33%). The evaluated sample reflects the epidemiology of heart failure in Brazil and, although pharmacotherapy had been according to Brazilian Guidelines, apparently the monitoring was not performed as recommended. This work highlighs the necessity of plasma digoxin constant monitoring during pharmacotherapy and the development of protocols that enable a safer use, especially in male patients, functional class III and with renal dysfunction.
Title: Study of digoxin use in a public health unit
Description:
Digoxin is used for heart failure associated to systolic dysfunction and high ventricular rate.
It has a narrow therapeutic range and intoxication may occur due to drug interactions or comorbidities.
The aim of this work was to study digoxin use in a public health unit delineating the profile of patients susceptible to digitalis intoxication.
Medical records belonging to patients admitted to the cardiomyopathy ward of the health unit (2009-2010) and in use of digoxin were analyzed.
Among 647 patients admitted, 185 individuals using digoxin and possessed records available.
The registration of plasma digoxin concentration was found in 80 records and it was out of the therapeutic range in 42 patients (52.
5%).
This group of individuals was constituted mainly by males patients (79%), functional class III of heart failure (65%), exhibiting renal failure (33%).
The evaluated sample reflects the epidemiology of heart failure in Brazil and, although pharmacotherapy had been according to Brazilian Guidelines, apparently the monitoring was not performed as recommended.
This work highlighs the necessity of plasma digoxin constant monitoring during pharmacotherapy and the development of protocols that enable a safer use, especially in male patients, functional class III and with renal dysfunction.
Related Results
Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
Background: Digoxin is extensively prescribed for cardiac diseases, so its chronic or acute toxicity commonly occur. Although digoxin specific antibodies (anti-digoxin Fab) are rec...
Vị trí của digoxin trong điều trị suy tim
Vị trí của digoxin trong điều trị suy tim
Qua phân tích các chứng cứ nêu trên và tham khảo các hướng dẫn điều trị hiện hành, có thể kết luận tóm tắt về việc dùng digoxin điều trị suy tim mạn như tr...
Digoxin: Review of Current Laboratory Practice and Considerations
Digoxin: Review of Current Laboratory Practice and Considerations
Digoxin is a drug used for its effects on the heart, particularly its effect on rate and strength of contraction. Levels are particularly useful in clinical practice owing to its n...
ACKNOWLEDGMENTS
ACKNOWLEDGMENTS
The UP Manila Health Policy Development Hub recognizes the invaluable contribution of the participants in theseries of roundtable discussions listed below:
RTD: Beyond Hospit...
Digoxin-quinidine interaction in patients with chronic renal failure.
Digoxin-quinidine interaction in patients with chronic renal failure.
We evaluated the effect of quinidine on digoxin pharmacokinetic in six patients with severe renal failure. Quinidine reduced the total body clearance of digoxin from 1.87 to 1.06 l...
Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects
Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects
Abstract
Background
To investigate the effects of coadministration of esaxerenone with amlodipine on the pharmacokinetics (PK) of each drug, and of esaxerenone on the PK of digoxin...
Double-Blind Placebo-Controlled Trial of Digoxin in Symptomatic Paroxysmal Atrial Fibrillation
Double-Blind Placebo-Controlled Trial of Digoxin in Symptomatic Paroxysmal Atrial Fibrillation
Background
—Digoxin is commonly prescribed in symptomatic paroxysmal atrial fibrillation (AF) but has never been evaluated in this condition.
...

